|
CLIP4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.75429679064132E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8436030480018E-11 |
| Normal-vs-Stage2 |
8.561800E-03 |
| Normal-vs-Stage3 |
2.32390000021176E-07 |
| Normal-vs-Stage4 |
3.80229999999981E-05 |
| Stage1-vs-Stage2 |
1.391560E-01 |
| Stage1-vs-Stage3 |
3.816800E-01 |
| Stage1-vs-Stage4 |
5.816000E-01 |
| Stage2-vs-Stage3 |
4.097200E-01 |
| Stage2-vs-Stage4 |
4.390800E-01 |
| Stage3-vs-Stage4 |
9.172600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44679848499163E-11 |
| Normal-vs-AfricanAmerican |
1.66319999994613E-07 |
| Normal-vs-Asian |
4.0478000000066E-05 |
| Caucasian-vs-AfricanAmerican |
3.939000E-01 |
| Caucasian-vs-Asian |
8.414000E-01 |
| AfricanAmerican-vs-Asian |
5.343200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.50560000209555E-09 |
| Normal-vs-Female |
9.40939548499387E-11 |
| Male-vs-Female |
9.651200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.73681119170533E-12 |
| Normal-vs-Age(41-60Yrs) |
2.00119999460568E-08 |
| Normal-vs-Age(61-80Yrs) |
3.80010000000652E-05 |
| Normal-vs-Age(81-100Yrs) |
3.152200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.797700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.922200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.570100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.101200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.186800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.289600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.750400E-02 |
| Classical-VS-Follicular |
6.28889999999549E-05 |
| Classical-VS-Other |
1.079990E-01 |
| Classical-VS-Normal |
8.64863736182997E-14 |
| Tall-VS-Follicular |
1.365350E-01 |
| Tall-VS-Other |
7.180400E-01 |
| Tall-VS-Normal |
7.50990000000229E-05 |
| Follicular-VS-Other |
6.868800E-01 |
| Follicular-VS-Normal |
9.538900E-03 |
| Other-VS-Normal |
3.213800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.47729999963897E-07 |
| Normal-vs-N1 |
1.79791999999068E-05 |
| N0-vs-N1 |
9.652300E-02 |
|
|
